FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/054293 [Registered on: 22/06/2023] Trial Registered Prospectively
Last Modified On: 21/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Other 
Public Title of Study   Study to compare Levobupivacaine heavy & Bupivacaine heavy in spinal anesthesia for below belly button operations. 
Scientific Title of Study   To compare the efficacy of hyperbaric Levobupivacaine(0.5%) versus hyperbaric Bupivacaine (0.5%) in subarachnoid block for infra umbilical surgeries. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rachna Gupta 
Designation  PG Resident 
Affiliation  Gajra raja Medical college 
Address  department of anaesthesiology, 7th floor ,1000 bedded hospital,gwalior

Gwalior
MADHYA PRADESH
474009
India 
Phone  8462024311  
Fax    
Email  ruchiguptaa2503@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jitendra Agrawal 
Designation  Professor 
Affiliation  Gajra raja Medical college 
Address  Department of Anaesthesiology, 7th floor , 1000 bedded hospital,gwalior

Gwalior
MADHYA PRADESH
474009
India 
Phone  9300009942  
Fax    
Email  drjagrawal9@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Jitendra Agrawal 
Designation  Professor 
Affiliation  Gajra raja Medical college 
Address  Department of Anaesthesiology, 7th floor , 1000 bedded hospital ,Gwalior


MADHYA PRADESH
474009
India 
Phone  9300009942  
Fax    
Email  drjagrawal9@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology, GRMC,Gwalior, Madhya Pradesh, 474009 
 
Primary Sponsor  
Name  Dr Rachna Gupta 
Address  senior girls hostel , jayarogya group of hospital . pincode 474009 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rachna Gupta  jayarogya group of hospitals  Department of Anaesthesiology, 1000 bedded hospital ,Gwalior, Madhya Pradesh, 474009
Gwalior
MADHYA PRADESH 
8462024311

ruchiguptaa2503@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Gajra raja Medical College, Gwalior  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N433||Hydrocele, unspecified, (2) ICD-10 Condition: K409||Unilateral inguinal hernia, without obstruction or gangrene, (3) ICD-10 Condition: S829||Unspecified fracture of lower leg, (4) ICD-10 Condition: N814||Uterovaginal prolapse, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Bupivacaine heavy  3 ml of Bupivacaine 0.5% in subarachnoid block for infra umbilical surgeries 
Comparator Agent  Levobupivacaine heavy   3 ml of Levobupivacaine 0.5% in subarachnoid block for infra umbilical surgeries 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Age between 20-65 years
ASA grade I and II
Patient scheduled for infra umbilical surgeries 
 
ExclusionCriteria 
Details  Patients not giving consent to participate in the study.
Uncooperative patient
Patients with respiratory, cardiovascular, renal diseases, obesity.
Neurological disease (multiple sclerosis, symptomatic lumbar herniated disc,
spinal stenosis)
Abnormal coagulopathy
Patient with known hypersensitivity to local anaesthetic.
Local sepsis or infection 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Its expected that time of onset of motor block is shorter & lasted longer with bupivacaine 0.5% when compared with levobupivacaine0.5% .

Time to achieve highest sensory block is faster in levobupivacaine0.5% compared to bupivacaine 0.5% .  
12 HOURS 
 
Secondary Outcome  
Outcome  TimePoints 
Its expected that levobupivacaine heavy is haemodynamically more stable than bupivacaine heavy.  12 hours 
 
Target Sample Size   Total Sample Size="112"
Sample Size from India="112" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   30/06/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a prospective randomized controlled study to compare the efficacy of 3ml of levobupivacaine 0.5% when compared with 3 ml of bupivacaine 0.5% in subarachnoid block for infra umbilical surgeries . 
It is expected that levobupivacaine is haemodynamically more stable as compared to bupivacaine.
 
Close